Novo Nordisk Investigational Site
Tokyo, 1000005, Japan
NCT Number: NCT01620333
This trial is conducted in Japan. The aim of this trial is to investigate the pharmacokinetics of biphasic insulin aspart 50 (NN-X14Mix50) and biphasic insulin aspart 70 (NN-X14Mix70) in Japanese healthy volunteers.
Looking for future studies?
Notify Me20 year–40 year
Male
Interventional
Phase 1
Tokyo, 1000005, Japan
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A single dose of 0.08 U/kg body weight, administered subcutaneously (s.c., under the skin) on two dosing visits in random order separated by 6-12 days
A single dose of 0.08 U/kg body weight, administered subcutaneously (s.c., under the skin) on two dosing visits in random order separated by 6-12 days
Novo Nordisk A/S
Industry
A Randomised, Open-labelled, Single-centre, Two-period Crossover Trial Characterizing the Pharmacokinetics and Pharmacodynamics of NN-X14Mix50 and NN-X14Mix70 in Healthy Male Subjects
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05970601
Diabetes, Diabetes Mellitus
Düsseldorf, Germany
View Trial DetailsNCT01508897
Diabetes, Diabetes Mellitus
Neu-Ulm, Germany
View Trial DetailsNCT01507285
Diabetes, Diabetes Mellitus
Manchester, United Kingdom
View Trial DetailsNCT03983733
Behavior, Behavior, Animal
Boston, Massachusetts, United States
View Trial Details